PARSONS JAMES T. enters ONCOLYTICS BIOTECH INC with 31.85K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 1/2/2026ACC: 0001493152-26-000135
31.85K
Baseline shares
100% direct
31.85K
Direct ownership
1 position
255K
Derivative underlying
5 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Shares
DirectShares owned31.85K
Total
31.85K direct31.85K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 31.85K | Direct |
| Total | 31.85K | 31.85K direct |
Derivative Holdings5
Stock Option
DirectUnderlying security
Common Shares
Underlying shares
45K
Shares owned
N/A
Exercise price
1.14
Expiration
—
Exercise window
—
Stock Option
DirectUnderlying security
Common Shares
Underlying shares
120K
Shares owned
N/A
Exercise price
1.08
Expiration
—
Exercise window
—
Stock Option
DirectUnderlying security
Common Shares
Underlying shares
30K
Shares owned
N/A
Exercise price
1.13
Expiration
—
Exercise window
—
Stock Option
DirectUnderlying security
Common Shares
Underlying shares
30K
Shares owned
N/A
Exercise price
2.76
Expiration
—
Exercise window
—
Stock Option
DirectUnderlying security
Common Shares
Underlying shares
30K
Shares owned
N/A
Exercise price
1.08
Expiration
—
Exercise window
—
Total
Underlying
255K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option Direct | Common Shares | 1.14 | — | — | 45K | N/A |
| Stock Option Direct | Common Shares | 1.08 | — | — | 120K | N/A |
| Stock Option Direct | Common Shares | 1.13 | — | — | 30K | N/A |
| Stock Option Direct | Common Shares | 2.76 | — | — | 30K | N/A |
| Stock Option Direct | Common Shares | 1.08 | — | — | 30K | N/A |
| Total | 255K | 0.00 | ||||